Konstantin Kubsch und Klaus - Info zur Person

(1 - 7 von 7

)

Martin RAIDA | Medical Director | Doctor of MedicineResearchGate

www.researchgate.net

Konstantin Kubsch · Martin Raida; [...] Klaus Höffken. Purpose: To study efficacy and tolerability of ... Konstantin Kubsch · Martin Raida; [...] Klaus Höffken. Purpose: To study efficacy and tolerability of ...

Chronomodulated chemotherapy in metastatic gastrointestinal cancer...

www.proquest.com

Kay-Oliver Kliche Æ Konstantin Kubsch Æ Martin Raida. Rami Masri-Zada Æ Klaus Ho¨ffken. Chronomodulated chemotherapy in metastatic gastrointestinal ...

Chronomodulated chemotherapy in metastatic ...Springer

link.springer.com

von KO Kliche · · Zitiert von: 16 — Kay-Oliver Kliche Æ Konstantin Kubsch Æ Martin Raida. Rami Masri-Zada Æ Klaus Ho¨ffken. Chronomodulated chemotherapy in metastatic gastrointestinal cancer. von KO Kliche · · Zitiert von: 16 — Kay-Oliver Kliche Æ Konstantin Kubsch Æ Martin Raida. Rami Masri-Zada Æ Klaus Ho¨ffken. Chronomodulated chemotherapy in metastatic gastrointestinal cancer.

Chronomodulated chemotherapy in metastatic gastrointestinal cancer...

link.springer.com

Authors. Kay-Oliver Kliche · -jena.de (A1); Konstantin Kubsch (A1); Martin Raida (A1); Rami Masri-Zada (A2); Klaus Höffken (A1).

the Jena experience in 79 patientsNational Institutes of Health (NIH) (.gov)

pubmed.ncbi.nlm.nih.gov

von KO Kliche · · Zitiert von: 16 — Konstantin Kubsch, Martin Raida, Rami Masri-Zada, Klaus Höffken. Affiliation. 1 Department of Internal Medicine II, Friedrich-Schiller University, Erlanger ... von KO Kliche · · Zitiert von: 16 — Konstantin Kubsch, Martin Raida, Rami Masri-Zada, Klaus Höffken. Affiliation. 1 Department of Internal Medicine II, Friedrich-Schiller University, Erlanger ...